BSD gets FDA's approval for cancer treatment device

BSD Medical Corp. said Tuesday that it has received U.S. Food and Drug Administration approval to market a new microwave generator designed to treat several types of cancers.

Salt Lake-based BSD said the generator is designed for treating prostate, cervical, breast and head and neck cancers through interstitial hyperthermia therapy.

The new generator supports advanced treatment steering through electronic phase control, which allows an operator to electronically direct and shape the pattern of hyperthermia treatments based on the positioning of the microwave antennae array used in treating the tumor. The treatment pattern can thereby be electronically targeted on the tumor position, shape and size, BSD said.

The FDA approval finishes the final phase of the commercial introduction of four new cancer treatment systems for sale in the United States by BSD.